These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26945268)

  • 21. Prevalence of overactive bladder and stress urinary incontinence in women who have sex with women: an internet-based survey.
    Sturm RM; Breyer BN; Li CS; Subak LL; Brown JS; Shindel AW
    J Womens Health (Larchmt); 2014 Nov; 23(11):935-40. PubMed ID: 25314336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Risk Factors of Urinary Incontinence and Overactive Bladder in Japanese Women.
    Ninomiya S; Naito K; Nakanishi K; Okayama H
    Low Urin Tract Symptoms; 2018 Sep; 10(3):308-314. PubMed ID: 28762631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of urinary symptoms in patients with post-prostatectomy urinary incontinence treated with the male sling TOMS.
    Yiou R; Loche CM; Lingombet O; Abbou C; Salomon L; de la Taille A; Audureau E
    Neurourol Urodyn; 2015 Jan; 34(1):12-7. PubMed ID: 24142704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of urodynamic characteristics between female patients with overactive bladder and overactive bladder plus stress urinary incontinence.
    Lin LY; Yeh NH; Lin CY; Sheu BC; Lin HH
    Urology; 2004 Nov; 64(5):945-9. PubMed ID: 15533483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of OAB symptoms on work, quality of life and treatment-seeking behavior in Brazil.
    Gomes CM; Averbeck MA; Koyama M; Soler R
    Curr Med Res Opin; 2020 Aug; 36(8):1403-1415. PubMed ID: 32329367
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of overactive bladder, stress and mixed urinary incontinence on quality of life in Thai postmenopausal women.
    Bunyavejchevin S
    J Med Assoc Thai; 2006 Mar; 89(3):294-8. PubMed ID: 16696411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distress and quality of life characteristics associated with seeking surgical treatment for stress urinary incontinence.
    Gil KM; Somerville AM; Cichowski S; Savitski JL
    Health Qual Life Outcomes; 2009 Feb; 7():8. PubMed ID: 19196462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment.
    Ellington DR; Szychowski JM; Malek JM; Gerten KA; Burgio KL; Richter HE
    Female Pelvic Med Reconstr Surg; 2016; 22(4):254-60. PubMed ID: 26945271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females.
    Nowakowski Ł; Futyma K; Ziętek A; Bogusiewicz M; Gałczyński K; Rechberger T
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():137-140. PubMed ID: 27852010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "bother" of urinary incontinence.
    Trutnovsky G; Ulrich D; Rojas RG; Mann K; Aigmueller T; Dietz HP
    Int Urogynecol J; 2014 Jul; 25(7):947-51. PubMed ID: 24515545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.